Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Gains from Investment Securities: 2010-2025

Historic Gains from Investment Securities for Ironwood Pharmaceuticals (IRWD) over the last 13 years, with Sep 2025 value amounting to -$7,000.

  • Ironwood Pharmaceuticals' Gains from Investment Securities was N/A to -$7,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $8.4 million, marking a year-over-year change of. This contributed to the annual value of $12.6 million for FY2024, which is 116.00% up from last year.
  • According to the latest figures from Q3 2025, Ironwood Pharmaceuticals' Gains from Investment Securities is -$7,000, which was down 100.09% from $7.7 million recorded in Q4 2024.
  • Ironwood Pharmaceuticals' Gains from Investment Securities' 5-year high stood at $10.0 million during Q4 2023, with a 5-year trough of -$5.6 million in Q3 2021.
  • Moreover, its 3-year median value for Gains from Investment Securities was $368,500 (2024), whereas its average is $3.1 million.
  • In the last 5 years, Ironwood Pharmaceuticals' Gains from Investment Securities crashed by 194.99% in 2021 and then skyrocketed by 3,342.11% in 2024.
  • Ironwood Pharmaceuticals' Gains from Investment Securities (Quarterly) stood at -$4.2 million in 2021, then soared by 242.10% to $5.9 million in 2022, then spiked by 68.03% to $10.0 million in 2023, then fell by 23.01% to $7.7 million in 2024, then reached -$7,000 in 2025.
  • Its last three reported values are -$7,000 in Q3 2025, $7.7 million for Q4 2024, and $121,000 during Q2 2024.